Tag: Drugs Controller General of India
DCGI gives approval to anti-COVID drug ‘Colchicine’ for phase 2 clinical...
Drugs Controller General of India (DCGI) has given approval to a two-arm phase-II clinical trial to assess the safety and efficacy of the drug Colchicine in the improvement of clinical outcomes during the treatment of COVID-19 patients...........................